Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry

Дата публикации: 22-10-2026 22:08:24

Drug discovery chemistry startup Warp Sciences Inc. launched today with $215 million in new funding, six months after co-founder and Chief Executive Kevin Weil left his job running science initiatives at OpenAI Group PBC. Warp is building a chemistry contract research organization in the U.S. to supply biotech and pharmaceutical companies with the molecules their […]
The post Ex-OpenAI science chief Kevin Weil launches Warp Sciences with $215M for drug chemistry appeared first on SiliconANGLE.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	AI drug development startup Pathos AI closes $237M investment	0	9.13	23-10-2026
2	Report: OpenAI closing on $30B ‘bridge’ funding round to tide it over before IPO	0	6.89	23-10-2026
3	In AI, it’s a tale of two diverging investor classes	0	8.3	23-10-2026
4	Stripe reportedly finalizes deal to buy AI model router OpenRouter for more than $7B	0	6.22	16-08-2026
5	Бывший топ-менеджер OpenAI Кевин Вейл вошел в совет директоров Stoke ...	0	5	08-07-2026
6	You know OpenAI and Nvidia. These are the AI companies building everything else	0	7	26-06-2026
7	NYT: OpenAI mulls delaying IPO over valuation concerns	0	5	26-06-2026
8	Former AWS CEO Adam Selipsky to lead new $10B AI data center venture	0	22.87	11-06-2026
9	Nvidia Opens Israel AI Lab Aimed at Faster Drug and Medical Discoveries	0	14.17	23-09-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 7.23. Источник: siliconangle.com.